BRIEF-Galena Biopharma announces completion of enrollment in two NeuVax™ clinical trials in combination with Trastuzumab [Reuters]
GALENA BIOPHARMA (GALE)
US:NASDAQ Investor Relations:
globenewswire.com/news-release/2017/12/29/1276660/0/en/galena-biopharma-inc-stockholders-approve-business-combination-with-sellas-life-sciences-group-ltd-board-sets-reverse-stock-split-ratio.html
Company Research
Source: Reuters
BRIEF-Galena Biopharma announces completion of enrollment in two NeuVax™ clinical trials in combination with Trastuzumab | Reuters Reuters Staff 1 Min Read Sept 28 (Reuters) - Galena Biopharma Inc * Galena Biopharma Inc announces completion of enrollment in two NeuVax™ (nelipepimut-s) clinical trials in combination with Trastuzumab * Galena Biopharma Inc - ?look forward to interim results next year for phase 2b trial and primary endpoints for both trials in 2019 * Galena Biopharma Inc - ?recommendation from dsmb was to continue her2 3+ trial unmodified? Source text for Eikon: Further company coverage: All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays. © 2017 Reuters. All Rights Reserved. BRIEF-Galena Biopharma announces completion of enrollment in two NeuVax™ clinical trials in combination with Trastuzumab Sept 28 (Reuters) - Galena Biopharma Inc * Galena Biopharma Inc announces completion of enrollment in two NeuVax™ (nelipepimu
Show less
Read more
Impact Snapshot
Event Time:
GALE
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
GALE alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
GALE alerts
High impacting GALENA BIOPHARMA news events
Weekly update
A roundup of the hottest topics